Cook Pharmica sold to Catalent Incorporated this morning.
According to separately filed press releases, New Jersey-based Catalent bought Cook Pharmica from the Bloomington-based Cook Group for $950 million.
The deal, which was announced this morning, is still subject to federal approval, but could go through within the next forty days.
Cook Group Spokeswoman Marsha Lovejoy says the sale of Cook Pharmica to Catalent won’t effect current employees.
Cook Pharmica employees were not informed of the sale of the company, until it was announced this morning.
Catalent Spokesman Elliot Berger says the publicly-traded company bought Cook Pharmica in order to expand their pharmaceutical reach into biologics— those are large and